DEVV Is Making Moves This Morning, Trading Green And Up An Approximate 75%
DEVV is making early moves today.
Trading in the green and up an approximate 75%, DEVV has already hit a high of $5.30!
Remember, this is a low float stock profile so we could be seeing the start of an ever bigger move.
Make sure to read my initial report below and get DEVV on your radar.
Accounting for $379Bn in 2017, the world-wide nutraceuticals market could see growth at a CAGR of 7.6% to reach $734.60Bn by 2026.
Those figures are just part of the reason I want you to focus your attention on this new stock idea for today, January 27th:
> Bioscience Neutraceuticals Inc. (DEVV) <
Yahoo Finance reports this stock to have a small float of approximately 7.8Mn shares.
Why is this important?
It means DEVV has a similar share structure to many of my massive short-term run wild champs.
Here are just an example of 4 recent low float runners over the past 4+ weeks. Soak these in:
- 12/27 (DINO) - Ran 171% intraday from a $.07 open to a $.19 high.
- 1/9 (JFIL) - Ran 81% intraday from a $.0385 open to a $.07 high.
- 1/21 (GNPX) - Ran 66.67% intraday from an approximate $1.20 release to a $2.00 high the following day.
- 1/23 (PHBI) - Ran 17% intraday from an open of $.615 to a high of $.72.
4 stock profiles. Over 335% in potential gains overall. Not shabby.
Listen. That was then; this is now... Let's turn our complete attention to Bioscience Neutraceuticals Inc. (DEVV).
Before we get started, lets get the industry definition of "nutraceuticals" under our belts.
According to Wikipedia, Nutraceutical is a combination of the words “nutrition” and “pharmaceutical” that was coined in 1989 by Stephen L. DeFelice, the founder and chairman of the Foundation of Innovation Medicine.
The term is applied to products that range from isolated nutrients, dietary supplements and herbal products, specific diets and processed foods such as cereals, soups and beverages.
The increasing chances of health disorders and complexions such as obesity, cholesterol, high blood pressure & diabetes and increasing healthcare costs are some of the driving factors supporting market growth.
Because this industry tends to focus on prevention, the consumer base can be much wider: 29.1 million Americans have diabetes, for example, but some 86 million are at risk. All of them may benefit from a nutraceutical that helps regulate blood sugar.
Of course, not all 86 million know they’re prediabetic, much less are prepared to take preventative steps. But as interest in personal wellness increases and awareness campaigns continue, this could change.
One More Reason This Industry Shows Growth Potential
Another point in this industry’s favor? Nutraceuticals may not be as stringently regulated as pharmaceutical drugs or medical devices—which means they can get to market quicker.
In the United States, for example, it is the manufacturer’s responsibility to ensure a nutraceutical is safe. They do not have to obtain FDA approval before putting their product on the shelves, unless it contains a brand new food additive.
More About The Company: Bioscience Neutraceuticals Inc.
Full Company Details Here.
Bioscience Neutraceuticals, Inc. provides organic essential oil products. The company is involved in repackaging and rebranding pure oils for sale to the end customers. Its product line consists of tea tree, eucalyptus, castor, rosehip, lemon, cinnamon, cedarwood, lemongrass, and emu oils.
The company was founded in 2010 and is based in Chicago, Illinois.
Bioscience Neutraceuticals, Inc. wholly owns and operates Bio Health Products, Inc, a company which specializes in the wholesale and retail of essential oils.